Hepatitis C virus (HCV) represents a challenging global health threat to ~200 million infected individuals. Clinical data suggest that only ~10–15% of acutely HCV-infected individuals will achieve spontaneous viral clearance despite exuberant virus-specific immune responses, which is largely attributed to difficulties in recognizing the pathognomonic symptoms during the initial stages of exposure to the virus. Given the paucity of a suitable small animal model, it is also equally challenging to study the early phases of viral establishment. Further, the host factors contributing to HCV chronicity in a vast majority of acutely HCV-infected individuals largely remain unexplored. The last few years have witnessed a surge in studies showing that HCV adopts myriad mechanisms to disconcert virus-specific immune responses in the host to establish persistence, which includes, but is not limited to viral escape mutations, viral growth at privileged sites, and antagonism. Here we discuss a few hitherto poorly explained mechanisms employed by HCV that are believed to lead to chronicity in infected individuals. A better understanding of these mechanisms would aid the design of improved therapeutic targets against viral establishment in susceptible individuals.

Early detection of latent tuberculosis infection (LTBI) is critical to TB elimination in the current WHO vision of End Tuberculosis Strategy. The study investigates whether detecting plasma cytokines could aid in diagnosing LTBI across household contacts (HHCs) positive for IGRA, HHCs negative for IGRA, and healthy controls. The plasma cytokines were measured using a commercial Bio-Plex Pro Human Cytokine 17-plex assay. Increased plasma CXCL8 and decreased MCP-1, TNF-α, and IFN-γ were associated with LTBI. Regression analysis showed that a combination of CXCL8 and MCP-1 increased the risk of LTBI among HHCs to 14-fold. Our study suggests that CXCL-8 and MCP-1 could serve as the surrogate biomarkers of LTBI, particularly in resource-limited settings. Further laboratory investigations are warranted before extrapolating CXCL8 and MCP-1 for their usefulness as surrogate biomarkers of LTBI in resource-limited settings.

The objective of this study was to evaluate the effect of surfactant on disperser homogenization pretreatment for macroalgae (Ulva intestinalis) to enhance biogas production. The macroalgae are subjected to surfactant coupled disperser pretreatment, which enhanced the liquefaction and improved the biomethane production. The outcome of this study revealed that 10,000 rpm at 20 min with a specific energy input of 1748.352 kJ/ kg total solids (TS) are the optimum conditions for surfactant disperser pretreatment (SDP), which resulted in the liquefaction rate of 20.08% with soluble organics release of 1215 mg/L and showed a better result than disperser pretreatment (DP) with a liquefaction rate of 14%. Biomethane production through the SDP method was found to be 0.2 g chemical oxygen demand (COD)/g COD, which was higher than DP (0.11 g COD/g COD). SDP was identified to be a synergetic pretreatment method with an energy ratio and net profit of about 0.91 and 104.04 United States dollars (USD)/ton, respectively.